BAZOCAR XR 600 TABLET

Product Description

BAZOCAR XR 600 TABLET Extended Release Oxcarbazepine 600mg for Superior Seizure Management

Product Description:

BAZOCAR XR 600 Tablet contains Oxcarbazepine 600mg in an advanced extended-release formulation designed for effective and sustained control of partial seizures and epilepsy. This once-daily tablet provides consistent therapeutic levels, enhancing patient compliance and minimizing side effects commonly associated with immediate-release antiepileptics.

Manufactured under strict WHO-GMP and DCGI-approved standards, BAZOCAR XR 600 is the ideal choice for neurologists, hospitals, pharmaceutical distributors, and bulk buyers seeking a reliable, high-quality anticonvulsant.

Key Benefits:

• Extended-release formulation ensures stable blood plasma concentration

• Enables once-daily dosing for improved patient adherence

• Effective in monotherapy and adjunctive epilepsy treatment

• Reduces risk of breakthrough seizures and side effects

• Backed by regulatory approvals and clinical efficacy

Indications:

• Management of partial-onset seizures in adults and children

• Adjunct therapy for epilepsy requiring steady medication levels

Ideal For:

• Neurology clinics & hospitals

• Pharmaceutical wholesalers & retailers

• Bulk procurement & institutional supplies

• Exporters & pharma franchise networks

Packaging:
Blister Packs | Custom Bulk Packaging Available
Certifications: WHO-GMP | DCGI Approved | ISO Certified
Shelf Life: 2436 months

BAZOCAR XR 600 Tablet by Agrosaf Pharmaceuticals Pvt. Ltd. offers advanced, sustained-release seizure control, making it a trusted solution for B2B pharma distributors, healthcare institutions, and epilepsy treatment providers.